spacer
spacer

PDBsum entry 5iv2

Go to PDB code: 
protein ligands Protein-protein interface(s) links
Immune system PDB id
5iv2

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
213 a.a.
216 a.a.
12 a.a.
Ligands
PO4 ×5
Waters ×617
PDB id:
5iv2
Name: Immune system
Title: Cetuximab fab in complex with arg9cir meditope variant
Structure: Cetuximab fab, light chain. Chain: a, c. Engineered: yes. Cetuximab fab, heavy chain. Chain: b, d. Engineered: yes. Meditope variant. Chain: e, f. Engineered: yes
Source: Mus musculus, homo sapiens. Mouse, human. Organism_taxid: 10090, 9606. Expressed in: unidentified. Expression_system_taxid: 32644. Synthetic: yes. Synthetic construct. Organism_taxid: 32630
Resolution:
2.48Å     R-factor:   0.167     R-free:   0.211
Authors: K.P.Bzymek,J.C.Williams
Key ref: K.P.Bzymek et al. (2016). Natural and non-natural amino-acid side-chain substitutions: affinity and diffraction studies of meditope-Fab complexes. Acta Crystallogr F Struct Biol Commun, 72, 820-830. PubMed id: 27834791
Date:
18-Mar-16     Release date:   26-Oct-16    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
No UniProt id for this chain
Struc: 213 a.a.
Protein chains
No UniProt id for this chain
Struc: 216 a.a.
Protein chains
No UniProt id for this chain
Struc: 12 a.a.
Key:    Secondary structure  CATH domain

 

 
Acta Crystallogr F Struct Biol Commun 72:820-830 (2016)
PubMed id: 27834791  
 
 
Natural and non-natural amino-acid side-chain substitutions: affinity and diffraction studies of meditope-Fab complexes.
K.P.Bzymek, K.A.Avery, Y.Ma, D.A.Horne, J.C.Williams.
 
  ABSTRACT  
 
Herein, multiple crystal structures of meditope peptide derivatives incorporating natural and unnatural amino acids bound to the cetuximab Fab domain are presented. The affinity of each derivative was determined by surface plasmon resonance and correlated to the atomic structure. Overall, it was observed that the hydrophobic residues in the meditope peptide, Phe3, Leu5 and Leu10, could accommodate a number of moderate substitutions, but these invariably reduced the overall affinity and half-life of the interaction. In one case, the substitution of Phe3 by histidine led to a change in the rotamer conformation, in which the imidazole ring flipped to a solvent-exposed position. Based on this observation, Phe3 was substituted by diphenylalanine and it was found that the phenyl rings in this variant mimic the superposition of the Phe3 and His3 structures, producing a moderate increase, of 1.4-fold, in the half-life of the complex. In addition, it was observed that substitution of Leu5 by tyrosine and glutamate strongly reduced the affinity, whereas the substitution of Leu5 by diphenylalanine moderately reduced the half-life (by approximately fivefold). Finally, it was observed that substitution of Arg8 and Arg9 by citrulline dramatically reduced the overall affinity, presumably owing to lost electrostatic interactions. Taken together, these studies provide insight into the meditope-cetuximab interaction at the atomic level.
 

 

spacer

spacer